Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Contraception
Antiangiogenic agents disrupt periovulatory events in monkeys
September 22nd, 2005
Antiangiogenic agents disrupt periovulatory events in monkeys. "To determine if antiangiogenic agents disrupt primate ovarian function, vehicle or a general angiostatic compound (TNP-470), specific antagonists of vascular endothelial growth factor (soluble VEGF receptor-1, sVEGFR-1; anti-VEGF monoclonal antibody, VEGF Ab) and/or an angiopoietin antagonist (Ang-2) were administered to rhesus monkeys: locally via injection into the preovulatory follicle at midcycle or the developing corpus luteum at the midluteal phase; or systemically via subcutaneous injection in the early follicular phase or at midcycle during the natural menstrual cycle," scientists in the United...
Source: Women's Health Weekly (2005-09-22)
|
